Skip to content

Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.

Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02732769
Acronym
Mask
Enrollment
58
Registered
2016-04-11
Start date
2016-02-29
Completion date
2018-03-21
Last updated
2018-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Metastases, Lung Cancer

Brief summary

the Mask fixation isn't a new solution for the immobilization of the patient's head and has been used in current practice for long years. This trial is attempting to compare these two technical possibilities of head fixation by mask or by stereotaxic frame. The primary goal is to evaluate the comfort for the patient and specifically for each step of the procedure. It will also evaluate other parameters such as the effectiveness of these two strategies and tolerance.The expected benefit is an improvement of the comfort for the patients.

Interventions

DEVICEGammaKnifePerfexion®

neurosurgery

DEVICEGammaKnifeIcon®

neurosurgery

DEVICEEfficast®

Thermoformed mask

DEVICEMRI

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject bearing of one to five intellectual metastases of lung origin at the time of the indication of the radiosurgery * Subject requiring a radiosurgical treatment with LGK

Exclusion criteria

* Subject having hurts of the brainstem or para-optics * Pregnant women or in feeding period * Subject having received previously a whole brain radiotherapy

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of pain during the hospitalization (3 days)12 monthsQuestionary (numeric pain intensity scale)

Secondary

MeasureTime frameDescription
Evaluation of tumor control at 3 months12 monthsNo increase of volume greater than 50% on the MRI
Evaluation of tumor control at 6 months12 monthsNo increase of volume greater than 50% on the MRI
Occurrence of clinical side effects12 monthsNumber of participants with treatment-related adverse events as assessed by CTCAE v4.0

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026